InvestLog
ANAB logo

ANAB

AnaptysBio, Inc.NASDAQHealthcare
$57.68+1.67%ClosedMarket Cap: $1.66B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-31Piper Sandler—Overweight—
2026-03-30HC Wainwright & Co.—Buy—
2026-03-17UBS—Buy—
2026-03-12Wedbush—Outperform—
2026-03-09Truist Securities—Hold—
2026-03-05Stifel—Buy—
2026-03-04Barclays—Overweight—
2026-01-20Barclays—Overweight—
2025-12-17Barclays—Overweight—
2025-12-11Stifel—Buy—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-3.83$157.1M7
Sun Dec 31$-0.34$265.3M7
Mon Dec 31$0.20$324.7M2
Tue Dec 31$4.06$489.6M5